Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 1;22(10):792-794.
doi: 10.2459/JCM.0000000000001192.

Compassionate drug use for patients with transthyretin amyloid cardiomyopathy

Giuseppe Ciliberti  1 , Alessia Urbinati, Alessandro Barbarossa, Giulia Stronati, Marco Silenzi, Samuele Principi, Umberto Falanga, Alessandro Capucci, Michela Casella, Antonio Dello Russo, Federico Guerra
Affiliations

Compassionate drug use for patients with transthyretin amyloid cardiomyopathy

Giuseppe Ciliberti et al. J Cardiovasc Med (Hagerstown). .
No abstract available

PubMed Disclaimer

References

    1. Maurer MS, Schwartz JH, Gundapaneni B, et al. ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018; 379:1007–1016. doi: 10.1056/NEJMoa1805689. - DOI
    1. Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133:2404–2412. doi: 10.1161/CIRCULATIONAHA.116.021612. - DOI
    1. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2019; 73:2872–2891. doi: 10.1016/j.jacc.2019.04.003. - DOI
    1. Kittleson MM, Maurer MS, Ambardekar AV, et al. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation 2020; 142:e7–e22. doi: 10.1161/CIR.0000000000000792. - DOI

MeSH terms

Supplementary concepts